Mette Kirstine Agger's Net Worth
$0
Who is Mette Kirstine Agger?
Mette Kirstine Agger does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Trevi Therapeutics, Inc., scPharmaceuticals Inc., IMARA Inc., and Lexeo Therapeutics, Inc..
SEC CIK
Mette Kirstine Agger's CIK is 0001722234
Past Insider Trading and Trends
2024 was Mette Kirstine Agger's most active year for acquiring shares with 3 total transactions. Mette Kirstine Agger's most active month to acquire stocks was the month of May. 2024 saw Mette Kirstine Agger paying a total of $0.00 for 73,750 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Trevi Therapeutics, Inc. (TRVI) Snapshot price: $2.95
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.15M |
$10.00 |
—
| 1.15M |
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
scPharmaceuticals Inc. (SCPH) Snapshot price: $5.3
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4/A
| +25.89% | 654.76K |
$14.00 | $9,166,668.00 | 3.18M |
Nov 21
| |||
Form 4
|
∞
| 2.53M |
—
|
—
| 2.53M |
Nov 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IMARA Inc. (ELVN) Snapshot price: $21.44
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.43M |
$16.00 |
—
| 1.43M |
Mar 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Lexeo Therapeutics, Inc. (LXEO) Snapshot price: $10.9
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||